Cerner closes on $375M deal that opens door to pharmaceutical business

With the acquisition of Kantar Health a wrap, Cerner has a vehicle for using its data to generate business in the pharmaceutical industry by potentially accelerating drugs to market.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Source Type: news